JIRE.US JPMorgan International Research Enhanced Equity ETF
- Total assets
- 11.3B
- Expense ratio
- 0.25%
- Dividend yield
- 2.84%
- 1-year return
- +12.65%
- Holdings
- 206
- Since
- 1992
Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.
What does JIRE.US invest in?
- Mostly Non-US stocks (95.6%)
- Largest sector: Financial Services (25.8%)
- Largest region: Europe Developed (49.2%)
- Top 3 holdings: 6.7% of the fund
Asset allocation
- Non-US stocks 95.6%
- US stocks 1.6%
- Cash 0.3%
- Other 0.3%
Top holdings
- ASML Holding N.V. 3.16%
- AstraZeneca PLC 1.81%
- Siemens Aktiengesellschaft 1.73%
- Allianz SE VNA O.N. 1.72%
- Roche Holding AG 1.59%
JPMorgan International Research Enhanced Equity ETF performance
Sharpe ratio 1.17- This year
- +10.89%
- 1 year
- +12.65%
- 3 years
- +17.41%
- 5 years
- +8.82%
Volatility 13.0% over 1 year and 11.7% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
JIRE.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About JPMorgan International Research Enhanced Equity ETF
Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It seeks to outperform the MSCI EAFE Index over time while maintaining similar risk characteristics, including sector and geographic risks. In implementing its strategy, the fund primarily invests in securities included within the universe of the index. In addition, it may also invest in securities not included within the index. The fund only invests in the securities of companies l…
Full fund profileJPMorgan International Research Enhanced Equity ETF top holdings
16.8% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| ASML Holding N.V. ASML.AS | Technology | Netherlands | 3.16% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 1.81% |
| Siemens Aktiengesellschaft SIE.XETRA | Industrials | Germany | 1.73% |
| Allianz SE VNA O.N. ALV.XETRA | Financial Services | Germany | 1.72% |
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 1.59% |
| Nestle S.A. NESN.SW | Consumer Defensive | Switzerland | 1.46% |
| HSBC Holdings PLC HSBA.LSE | Financial Services | United Kingdom | 1.39% |
| Novartis AG NOVN.SW | Healthcare | Switzerland | 1.34% |
| Shell plc SHEL.LSE | Energy | United Kingdom | 1.32% |
| Banco Santander S.A. SAN.MC | Financial Services | Spain | 1.26% |
The 10 largest of 206 holdings.
JIRE.US sector exposure
- Financial Services25.8%
- Industrials16.3%
- Healthcare11.6%
- Technology11.4%
- Consumer Cyclicals8.0%
- Consumer Defensive6.6%
- Basic Materials5.0%
- Communication Services4.9%
- Utilities4.1%
- Energy3.7%
- Real Estate0.6%
Share of the stocks in the fund.
JIRE.US regional exposure
- Europe Developed49.2%
- Japan24.2%
- United Kingdom17.3%
- Australasia6.7%
- Asia Developed2.9%
- North America1.5%
- Asia Emerging0.1%
Share of the stocks in the fund.
Company size
Average market cap 92.7B- Mega cap59.3%
- Big cap32.6%
- Medium cap4.2%
JPMorgan International Research Enhanced Equity ETF fund profile
- Fund name
- JPMorgan International Research Enhanced Equity ETF
- Ticker
- JIRE.US
- Exchange
- USA Stocks
- Issuer
- JPMorgan
- Index tracked
- -
- Category
- International Developed Equity (ex-US)
- Inception date
- Oct 28, 1992
- Trading currency
- USD
- Expense ratio
- 0.25%
- Annual turnover
- 0.2%
About JPMorgan International Research Enhanced Equity ETF
Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It seeks to outperform the MSCI EAFE Index over time while maintaining similar risk characteristics, including sector and geographic risks. In implementing its strategy, the fund primarily invests in securities included within the universe of the index. In addition, it may also invest in securities not included within the index. The fund only invests in the securities of companies located in developed markets.